BACKGROUND: Human herpesvirus 8 (HHV8), the infectious cause of Kaposi sarcoma, varies dramatically across Africa, suggesting that cofactors correlated with large-area geographic or environmental characteristics may influence risk of infection. Variation in HHV8 seropositivity across small-area regions within countries in Africa is unknown. We investigated this issue in Uganda, where Kaposi sarcoma distribution is uneven and well described. METHODS: Archival samples from individuals aged 15-59 years randomly selected from a nationally representative 2004-2005 human immunodeficiency virus-AIDS serobehavioral survey were tested for HHV8 seropositivity with use of enzyme immunoassays based on synthetic peptides from the K8.1 and orf65 viral genes. Adjusted odds ratios and 95% confidence intervals (CIs) of association of HHV8 seropositivity with demographic risk factors were estimated. RESULTS: Among 2681 individuals tested, HHV8 seropositivity was 55.4%. HHV8 seropositivity was lower in female than in male persons (adjusted odds ratio, 0.82 [95% CI, 0.69-0.97]) and increased 2.2% (95% CI, 1.0%-3.6%) in female persons and 1.2% (95% CI, 1.0%-2.3%) in male persons per year of age. HHV8 seropositivity was inversely associated with education ( P = .01, for trend) and was elevated in the West Nile region, compared with the Central region (adjusted odds ratio, 1.49 [95% CI, 1.02-2.18]) but not with other regions. CONCLUSIONS: Our findings suggest that HHV8 seropositivity in Uganda may be influenced by cofactors correlated with small-area geography, age, sex, and education.
BACKGROUND:Human herpesvirus 8 (HHV8), the infectious cause of Kaposi sarcoma, varies dramatically across Africa, suggesting that cofactors correlated with large-area geographic or environmental characteristics may influence risk of infection. Variation in HHV8 seropositivity across small-area regions within countries in Africa is unknown. We investigated this issue in Uganda, where Kaposi sarcoma distribution is uneven and well described. METHODS: Archival samples from individuals aged 15-59 years randomly selected from a nationally representative 2004-2005 human immunodeficiency virus-AIDS serobehavioral survey were tested for HHV8 seropositivity with use of enzyme immunoassays based on synthetic peptides from the K8.1 and orf65 viral genes. Adjusted odds ratios and 95% confidence intervals (CIs) of association of HHV8 seropositivity with demographic risk factors were estimated. RESULTS: Among 2681 individuals tested, HHV8 seropositivity was 55.4%. HHV8 seropositivity was lower in female than in male persons (adjusted odds ratio, 0.82 [95% CI, 0.69-0.97]) and increased 2.2% (95% CI, 1.0%-3.6%) in female persons and 1.2% (95% CI, 1.0%-2.3%) in male persons per year of age. HHV8 seropositivity was inversely associated with education ( P = .01, for trend) and was elevated in the West Nile region, compared with the Central region (adjusted odds ratio, 1.49 [95% CI, 1.02-2.18]) but not with other regions. CONCLUSIONS: Our findings suggest that HHV8 seropositivity in Uganda may be influenced by cofactors correlated with small-area geography, age, sex, and education.
Authors: E A Engels; M D Sinclair; R J Biggar; D Whitby; P Ebbesen; J J Goedert; J L Gastwirth Journal: Int J Cancer Date: 2000-12-15 Impact factor: 7.396
Authors: Mario Coluzzi; Maria Luisa Calabrò; Daniela Manno; Luigi Chieco-Bianchi; Thomas F Schulz; Valeria Ascoli Journal: J Infect Dis Date: 2004-07-01 Impact factor: 5.226
Authors: Jared M Baeten; Bhavna H Chohan; Ludo Lavreys; Joel P Rakwar; Rhoda Ashley; Barbra A Richardson; Kishorchandra Mandaliya; Job J Bwayo; Joan K Kreiss Journal: AIDS Date: 2002-10-18 Impact factor: 4.177
Authors: Wolfgang Hladik; Sheila C Dollard; Robert G Downing; Peter Kataaha; Philip E Pellett; John M Karon; Jonathan Mermin; Eve M Lackritz Journal: J Acquir Immune Defic Syndr Date: 2003-06-01 Impact factor: 3.731
Authors: Sam M Mbulaiteye; Ruth M Pfeiffer; Denise Whitby; Glen R Brubaker; John Shao; Robert J Biggar Journal: J Infect Dis Date: 2003-06-01 Impact factor: 5.226
Authors: Simon Brooker; Narcis B Kabatereine; Jennifer L Smith; Denise Mupfasoni; Mariam T Mwanje; Onésime Ndayishimiye; Nicholas Js Lwambo; Deborah Mbotha; Peris Karanja; Charles Mwandawiro; Eric Muchiri; Archie Ca Clements; Donald Ap Bundy; Robert W Snow Journal: Int J Health Geogr Date: 2009-07-09 Impact factor: 3.918
Authors: Murali Muniraju; Lorraine Z Mutsvunguma; Joslyn Foley; Gabriela M Escalante; Esther Rodriguez; Romina Nabiee; Jennifer Totonchy; David H Mulama; Joshua Nyagol; Felix Wussow; Anne K Barasa; Michael Brehm; Javier Gordon Ogembo Journal: J Virol Date: 2019-07-30 Impact factor: 5.103
Authors: Fatma M Shebl; Benjamin Emmanuel; Lisa Bunts; Benon Biryahwaho; Christine Kiruthu; Meei-Li Huang; Ruth M Pfeiffer; Corey Casper; Sam M Mbulaiteye Journal: J Med Virol Date: 2013-09 Impact factor: 2.327
Authors: Joanne T Chang; Fatma M Shebl; Ruth M Pfeiffer; Benon Biryahwaho; Barry I Graubard; Sam M Mbulaiteye Journal: Infect Agent Cancer Date: 2013-01-16 Impact factor: 2.965